TCL Archive In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos May 9, 1997
TCL Archive New CEO Brings Managed Care Expertise To Network Of Academic Cancer Centers January 24, 1997
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
